about
Ophthalmologic manifestations of celiac diseasePrevalence of celiac disease in an urban area of Brazil with predominantly European ancestryA snapshot of the nutritional status of Crohn's disease among adolescents in Brazil: a prospective cross-sectional study.Inter- and intraobserver agreement in computed tomography enterography in inflammatory bowel disease.Oral manifestations of inflammatory bowel disease: a review based on the observation of six cases.Histologic study of colonic mucosa in patients with chronic diarrhea and normal colonoscopic findings.Intestinal damage in strongyloidiasis: the imbalance between cell death and proliferation.Protective effect of metronidazole on uncoupling mitochondrial oxidative phosphorylation induced by NSAID: a new mechanismHelminths as an alternative therapy for intestinal diseasesLack of evidence for the pathogenic role of iron and HFE gene mutations in Brazilian patients with nonalcoholic steatohepatitis.Catheter-related septic thrombosis of superior vena cava and right heart in a patient with active Crohn's disease.Ursodeoxycholic acid ameliorates experimental ileitis counteracting intestinal barrier dysfunction and oxidative stress.Experimental evaluation of a model for predicting micellar composition and concentration of monomeric species in bile salt binary mixtures.Risk of thrombosis and mortality in inflammatory bowel disease.Pancreatic endosonographic findings and clinical correlation in Crohn's disease.Small bowel bacterial overgrowth in strongyloidiasisBile acids do not regulate the intestinal mucosal cholesterol synthesis: studies in the chronic bile duct-ureter fistula rat modelChylomicron metabolism in experimental cirrhosis and cholestasisEffects of colectomy on gallbladder motility in patients with ulcerative colitisGallbladder hypokinesia in Crohn's diseaseCeliac disease in Brazilian adultsCrohn's disease of the esophagus without inflammatory activity confirmed by the use of endoscopy with narrow-band imagingEye disorders in children with celiac diseaseManagement of inflammatory bowel disease patients in the COVID-19 pandemic era: a Brazilian tertiary referral center guidance
P50
Q26767425-E5112F09-22BE-4BB9-9FC1-481510169B76Q33909722-43B5183F-7705-457A-8DF8-F9ED6F85AF1FQ35862736-EAA4E529-201B-4D2C-B098-778A7BB4D1FAQ37483425-87F19CED-F5F6-47C2-81DB-6A3222B2E41AQ37529928-EF6D404D-346B-42C6-866C-734644BAD0F6Q38959707-EBEC703D-8003-4989-A644-617C78BFA4C6Q39587414-A44AEE74-9CB1-42CA-B74D-44098D456CC1Q42128208-E819999A-1F78-4BA9-AEDC-405CAE5A8731Q42358505-DC725D19-E096-422C-82D1-E3A6E36BCCECQ44469329-8A0B982D-A298-4BA3-BC06-434150C0092DQ44623688-D32A2AC1-5514-4147-8DF9-C245691D83DAQ45169694-399AF0F6-FE22-4B43-BE7C-5073C3634091Q52342807-27EA293E-5DA6-4862-BF3E-2D9C919ED892Q54959811-C2A54702-036E-47A4-844B-37A13350A87FQ64906561-7E969281-7A9C-4F06-A6ED-F0C741BF9A86Q67872041-7ACB2459-3C94-4AE0-B26C-3CFADCAC48E8Q68859469-CB405075-D660-4A36-A66A-6ACE21ED1FE4Q70774386-361C18BB-03D1-450A-A87C-CDE69D24927EQ73114655-166BDF8D-52C4-4F4D-8633-1A77AB3A0CF1Q73909720-3A44E594-B7A7-4BE0-81EC-AF39AE3488B9Q77801639-10C9979E-220F-4C51-8400-F140CFD77736Q84303607-BBAC65FF-5870-4ADF-961C-45EBD983673BQ87466252-4BDE3147-3A50-46DC-9A82-FC1D4FF20C9AQ93157253-0538CD0C-0E3E-4ED5-A001-D9FD59532DC2
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
A M Sipahi
@ast
A M Sipahi
@en
A M Sipahi
@es
A M Sipahi
@nl
type
label
A M Sipahi
@ast
A M Sipahi
@en
A M Sipahi
@es
A M Sipahi
@nl
prefLabel
A M Sipahi
@ast
A M Sipahi
@en
A M Sipahi
@es
A M Sipahi
@nl
P31
P496
0000-0002-9686-1627